Court OK's two copycat Zocors

A court ruling has cleared the way for two generic versions of the blockbuster cholesterol drug Zocor--from Teva and Ranbaxy--to be sold this year. A third "authorized" generic will be sold by another manufacturer in a pact with Merck. Analysts had expected up to 10 copycat Zocors on the market, which would have triggered a sudden plunge in the price of the drug. One analyst said the discount price would be about half of current retail with only three versions for sale. More competition could have dropped the price by 95 percent.

- read the Boston Globe report